CKG012 is an inhibitor of the Wnt/beta-catenin signaling pathway that inhibits the release of HMGB1 and the transcription of beta-catenin. It exhibits attenuating activities against cecal ligation and puncture (CLP)-induced sepsis and multiple myeloma cancer [1] [2].
Molekulargewicht:
357.4
CAS Nummer:
[2044497-76-7]
Formel:
C20H23NO5
Target-Kategorie:
Wnt/beta-catenin
T86065
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten